Rapid Micro Biosystems (RPID) Stock Price

Rapid Micro Biosystems Price

NASDAQ·CLOSED
2.10USD-0.06 (-2.82 %)
Market closed

Revenue has compounded at 5.0% per year over the past 15 years to 33.59 M USD. Rapid Micro Biosystems's net margin stands at -140.3%, up from -316.5% several years earlier. Analysts set a median price target of 8.16 USD, implying 288.6% above the current price. Of 10 analysts, 9 rate the stock a buy — an overall Buy consensus. The stock trades about 27% above its 52-week low.

Rapid Micro Biosystems stock price

Volume
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of Rapid Micro Biosystems over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Rapid Micro Biosystems stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Rapid Micro Biosystems's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Rapid Micro Biosystems Stock Price History
DateRapid Micro Biosystems Price
8/5/20262.10 USD
8/4/20262.16 USD
8/3/20262.12 USD
7/31/20262.13 USD
7/30/20262.11 USD
7/29/20262.03 USD
7/27/20261.98 USD
7/23/20261.99 USD
7/22/20262.06 USD
7/21/20262.10 USD
7/20/20262.07 USD
7/17/20262.07 USD
7/16/20262.09 USD
7/15/20262.21 USD
7/14/20262.07 USD
7/13/20262.00 USD
7/10/20262.05 USD
7/9/20261.74 USD
7/8/20261.71 USD
7/7/20261.74 USD
7/6/20261.72 USD
7/2/20261.72 USD
7/1/20261.71 USD
6/30/20261.73 USD
6/29/20261.73 USD
6/26/20261.70 USD
6/25/20261.70 USD
6/24/20261.68 USD
6/23/20261.69 USD
6/22/20261.71 USD
6/18/20261.71 USD
6/17/20261.68 USD
6/16/20261.66 USD
6/15/20261.72 USD
6/12/20261.76 USD
6/11/20261.88 USD
6/10/20261.89 USD
6/9/20261.88 USD
6/8/20261.99 USD
6/5/20261.99 USD
6/4/20261.99 USD
6/3/20261.96 USD
6/2/20261.96 USD
6/1/20261.97 USD
5/29/20262.01 USD
5/28/20262.02 USD
5/27/20261.96 USD
5/26/20262.01 USD
5/22/20262.05 USD
5/21/20262.07 USD
5/20/20262.01 USD
5/19/20261.98 USD
5/18/20261.96 USD
5/15/20262.07 USD
5/14/20262.32 USD
5/13/20262.48 USD
5/12/20262.58 USD
5/11/20262.58 USD
5/8/20262.63 USD
5/7/20262.56 USD
5/6/20262.53 USD
5/5/20262.48 USD
5/4/20262.49 USD
5/1/20262.53 USD
4/30/20262.40 USD
4/29/20262.30 USD
4/28/20262.46 USD
4/27/20262.36 USD
4/24/20262.28 USD
4/23/20262.23 USD
4/22/20262.38 USD
4/21/20262.19 USD
4/20/20262.25 USD
4/17/20262.28 USD
4/16/20262.26 USD
4/15/20262.35 USD
4/14/20262.19 USD
4/13/20262.13 USD
4/10/20262.12 USD
4/9/20262.12 USD
4/8/20262.29 USD
4/7/20262.17 USD
4/6/20262.21 USD
4/2/20262.27 USD
4/1/20262.16 USD
3/31/20262.27 USD
3/30/20262.22 USD
3/27/20262.20 USD
3/26/20262.28 USD
3/25/20262.43 USD
3/24/20262.40 USD
3/23/20262.30 USD
3/20/20262.35 USD
3/19/20262.50 USD
3/18/20262.68 USD
3/17/20262.92 USD
3/16/20262.97 USD
3/13/20262.83 USD
3/12/20263.43 USD
3/11/20264.38 USD
3/10/20264.13 USD
3/9/20264.20 USD
3/6/20264.12 USD
3/5/20264.17 USD
3/4/20264.36 USD
3/3/20264.24 USD
3/2/20264.40 USD
2/27/20264.33 USD
2/26/20264.47 USD
2/25/20264.39 USD
2/24/20264.13 USD
2/23/20263.99 USD
2/20/20263.89 USD
2/19/20263.97 USD
2/18/20264.17 USD
2/17/20263.94 USD
2/13/20263.91 USD
2/12/20263.81 USD
2/11/20264.20 USD
2/10/20264.08 USD
2/9/20263.75 USD
2/6/20263.87 USD
2/5/20263.68 USD
2/4/20263.89 USD
2/3/20264.35 USD
2/2/20264.19 USD
1/30/20264.43 USD
1/29/20264.68 USD
1/28/20264.65 USD
1/27/20264.25 USD
1/26/20264.22 USD
1/23/20264.12 USD
1/22/20264.41 USD
1/21/20264.61 USD
1/20/20264.40 USD
1/16/20264.18 USD
1/15/20263.45 USD
1/14/20263.68 USD
1/13/20263.04 USD
1/12/20263.07 USD
1/9/20263.13 USD
1/8/20263.25 USD
1/7/20263.34 USD
1/6/20263.38 USD
1/5/20263.06 USD
1/2/20263.14 USD
12/31/20252.90 USD
12/30/20252.75 USD
12/29/20252.90 USD
12/26/20252.98 USD
12/24/20253.10 USD
12/23/20253.05 USD
12/22/20253.17 USD
12/19/20253.15 USD
12/18/20253.34 USD
12/17/20253.34 USD
12/16/20253.52 USD
12/15/20253.47 USD
12/12/20253.64 USD
12/11/20253.72 USD
12/10/20253.96 USD
12/9/20253.88 USD
12/8/20253.98 USD
12/5/20253.98 USD
12/4/20254.03 USD
12/3/20254.00 USD
12/2/20254.09 USD
12/1/20254.12 USD
11/28/20254.19 USD
11/26/20254.14 USD
11/25/20254.15 USD
11/24/20254.11 USD
11/21/20254.17 USD
11/20/20254.06 USD
11/19/20254.36 USD
11/18/20254.36 USD
11/17/20254.14 USD
11/14/20254.21 USD
11/13/20254.46 USD
11/12/20254.14 USD
11/11/20253.76 USD
11/10/20253.24 USD
11/7/20253.10 USD
11/6/20252.75 USD
11/5/20252.87 USD
11/4/20252.70 USD
11/3/20252.75 USD
10/31/20252.99 USD
10/30/20252.91 USD
10/29/20252.87 USD
10/28/20252.91 USD
10/27/20252.95 USD
10/24/20252.93 USD
10/23/20252.77 USD
10/22/20252.74 USD
10/21/20252.93 USD
10/20/20253.14 USD
10/17/20253.08 USD
10/16/20252.94 USD
10/15/20253.18 USD
10/14/20253.26 USD
10/13/20253.49 USD
10/10/20253.21 USD
10/9/20253.59 USD
10/8/20253.50 USD
10/7/20253.69 USD
10/6/20253.69 USD
10/3/20253.79 USD
10/2/20253.53 USD
10/1/20253.46 USD
9/30/20253.34 USD
9/29/20253.30 USD
9/26/20253.27 USD
9/25/20253.21 USD
9/24/20253.16 USD
9/23/20253.25 USD
9/22/20253.34 USD
9/19/20253.37 USD
9/18/20253.22 USD
9/17/20253.05 USD
9/16/20253.04 USD
9/15/20253.15 USD
9/12/20253.03 USD
9/11/20252.93 USD
9/10/20253.01 USD
9/9/20252.67 USD
9/8/20252.72 USD
9/5/20252.72 USD
9/4/20252.44 USD
9/3/20252.38 USD
9/2/20252.37 USD
8/29/20252.41 USD
8/28/20252.51 USD
8/27/20252.56 USD
8/26/20252.64 USD
8/25/20252.64 USD
8/22/20252.85 USD
8/21/20252.68 USD
8/20/20252.49 USD
8/19/20252.46 USD
8/18/20252.65 USD
8/15/20252.62 USD
8/14/20252.82 USD
8/13/20252.91 USD
8/12/20252.68 USD
8/11/20253.26 USD
8/8/20253.40 USD
8/7/20253.35 USD
8/6/20253.41 USD
Access this data via the Eulerpool API
Get Free API Key

Rapid Micro Biosystems Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2022
17.13 M USD
-63.22 M USD
-60.81 M USD
Jan 1, 2023
22.52 M USD
-56.56 M USD
-52.47 M USD
Jan 1, 2024
28.05 M USD
-49.92 M USD
-46.89 M USD
Jan 1, 2025
33.59 M USD
-47.39 M USD
-47.12 M USD
Jan 1, 2026 (e)
39.30 M USD
-39.30 M USD
-41.22 M USD
Jan 1, 2027 (e)
46.58 M USD
-46.58 M USD
-35.01 M USD
Jan 1, 2028 (e)
65.00 M USD
-65.00 M USD
-20.83 M USD
Jan 1, 2029 (e)
74.70 M USD
-74.70 M USD
-20.83 M USD

Rapid Micro Biosystems Income Statement, Balance Sheet, Cash Flow Statement

Last updated Aug 6, 2026, 4:21 AM
 
REVENUEM USD
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEM USD
EBITM USD
EBIT MARGIN%
NET INCOMEM USD
NET INCOME GROWTH%
SHARESM
2010201120192020202120222023202420252026e2027e2028e2029e
16.0010.0016.0016.0023.0017.0022.0028.0033.0039.0046.0065.0074.00
–-37.5060.00–43.75-26.0929.4127.2717.8618.1817.9541.3013.85
43.7570.0043.75-50.00-30.43-47.06-22.7325.0021.2121.2121.2121.2121.21
7.007.007.00-8.00-7.00-8.00-5.007.007.008.279.7613.7915.70
––-18.00-33.00-70.00-63.00-56.00-49.00-47.00-39.00-46.00-65.00-74.00
––-112.50-206.25-304.35-370.59-254.55-175.00-142.42-100.00-100.00-100.00-100.00
––-21.00-37.00-73.00-60.00-52.00-46.00-47.00-41.00-35.00-20.00-20.00
–––76.1997.30-17.81-13.33-11.542.17-12.77-14.63-42.86–
44.6244.6231.7531.7541.8642.6043.1443.7744.6244.6244.6244.6244.62
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Rapid Micro Biosystems generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Rapid Micro Biosystems retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Rapid Micro Biosystems's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Rapid Micro Biosystems has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Rapid Micro Biosystems's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Rapid Micro Biosystems stock margins

The Rapid Micro Biosystems margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Rapid Micro Biosystems. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Rapid Micro Biosystems.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2021
-33.32 %
-304.68 %
-316.48 %
Jan 1, 2022
-49.85 %
-368.99 %
-354.91 %
Jan 1, 2023
-24.36 %
-251.18 %
-232.99 %
Jan 1, 2024
-0.39 %
-177.96 %
-167.16 %
Jan 1, 2025
22.65 %
-141.10 %
-140.30 %
Jan 1, 2026 (e)
22.65 %
-100.00 %
-104.88 %
Jan 1, 2027 (e)
22.65 %
-100.00 %
-75.18 %
Jan 1, 2028 (e)
22.65 %
-100.00 %
-32.05 %

Rapid Micro Biosystems Stock Revenue, EBIT, Earnings per Share

The Rapid Micro Biosystems earnings per share therefore indicates how much revenue Rapid Micro Biosystems has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2021
0.56 USD
-1.69 USD
-1.76 USD
Jan 1, 2022
0.40 USD
-1.48 USD
-1.43 USD
Jan 1, 2023
0.52 USD
-1.31 USD
-1.22 USD
Jan 1, 2024
0.64 USD
-1.14 USD
-1.07 USD
Jan 1, 2025
0.75 USD
-1.06 USD
-1.06 USD
Jan 1, 2026 (e)
0.89 USD
-0.88 USD
-0.93 USD
Jan 1, 2027 (e)
1.05 USD
-1.04 USD
-0.79 USD
Jan 1, 2028 (e)
1.47 USD
-1.46 USD
-0.47 USD

Rapid Micro Biosystems business model & stock analysis

Rapid Micro Biosystems Inc is a company specialized in the manufacturing of automated microbiology analysis systems. It was founded in 2006 and is headquartered in Lowell, Massachusetts, USA. The founders aimed to automate microbiology analysis in laboratories to achieve faster and more reliable results. They developed an innovative system that allows for sample analysis within a few hours, with higher accuracy compared to traditional methods. Rapid Micro Biosystems Inc's business model is based on the development and marketing of automated microbiology analysis systems for various industries, including pharmaceutical, medical device, cosmetic, food, and beverage. The company offers products such as the Growth DirectTM microbiology analysis systems that provide advantages in optimizing production processes, reducing time for sample verification, enabling quick detection of errors, and ensuring high quality and reliability. In summary, Rapid Micro Biosystems Inc is an innovative company specializing in the development and marketing of automated microbiology analysis systems. They have gained a significant customer base in different industries and provide solutions and technologies that optimize production processes while meeting the highest quality standards.

Rapid Micro Biosystems SWOT Analysis

Strengths

Rapid Micro Biosystems Inc possesses several strengths that contribute to its competitive advantage in the market. These include:

  • Advanced technology: Rapid Micro Biosystems Inc utilizes cutting-edge technology in its products, providing accurate and efficient microbial detection solutions.
  • Strong research and development capabilities: The company invests significantly in R&D, allowing for continuous innovation and the development of new products.
  • Strong customer base: Rapid Micro Biosystems Inc has established long-term relationships with a diverse range of customers in various industries, ensuring a steady revenue stream.
  • Well-trained workforce: The company boasts a highly skilled and knowledgeable team, enabling efficient operations and prompt customer support.

Weaknesses

Despite its strengths, Rapid Micro Biosystems Inc also faces certain weaknesses that may hinder its growth and success:

  • Relatively small market share: The company operates in a highly competitive industry and faces intense competition from larger, more established players.
  • High production costs: The advanced technology utilized by Rapid Micro Biosystems Inc requires substantial investments, resulting in higher production costs compared to some competitors.
  • Limited geographical presence: The company's operations are primarily focused in specific markets, limiting its exposure to potential customers in other regions.

Opportunities

Several opportunities exist for Rapid Micro Biosystems Inc to further expand and enhance its business:

  • Growing demand for microbial detection solutions: With increasing regulatory requirements and the need for improved manufacturing processes, there is a growing demand for advanced microbial detection solutions.
  • International expansion: By leveraging its existing customer base and technology, the company can explore opportunities to expand its operations into new geographic markets.
  • Strategic partnerships: Collaborations with other companies in related industries could provide access to complementary technologies and enhance market reach.

Threats

Rapid Micro Biosystems Inc must address several potential threats that could impact its business negatively:

  • Intense competition: The microbial detection industry is highly competitive, with numerous players vying for market share. Rapid Micro Biosystems Inc must continuously innovate to stay ahead.
  • Technological advancements: The rapid pace of technological advancements in the industry means that competing companies may develop more advanced products, potentially rendering current technologies obsolete.
  • Regulatory challenges: Compliance with evolving regulatory standards and requirements can pose challenges and increase costs for Rapid Micro Biosystems Inc.

Rapid Micro Biosystems Employees

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Rapid Micro Biosystems Employees
Details
Date
Rapid Micro Biosystems Employees
Jan 1, 2021
- Employees
Jan 1, 2022
- Employees
Jan 1, 2023
- Employees
Jan 1, 2024
- Employees
Jan 1, 2025
- Employees

Rapid Micro Biosystems Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Rapid Micro Biosystems historical P/E ratio, EBIT multiple, and P/S ratio

Rapid Micro Biosystems annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Rapid Micro Biosystems shares outstanding

The number of shares of Rapid Micro Biosystems was 44.62 M in 2025. This indicates how many shares Rapid Micro Biosystems is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2021
41.86 M Stocks
Jan 1, 2022
42.60 M Stocks
Jan 1, 2023
43.14 M Stocks
Jan 1, 2024
43.77 M Stocks
Jan 1, 2025
44.62 M Stocks
Jan 1, 2026 (e)
44.62 M Stocks
Jan 1, 2027 (e)
44.62 M Stocks
Jan 1, 2028 (e)
44.62 M Stocks

Current Rapid Micro Biosystems forecasts and price targets in August 2026

Analyst Price Targets 2026
Δ MOM Price Target
0.00 %
Buy
90.00 % (9)
Hold
10.00 % (1)
Sell
0.00 % (0)
12M Price Target
8.16
Last Price
2.10
Currency
USD
12M Return Potential
288.57 %
LTM Return
0 %

Rapid Micro Biosystems Analyst Rating Actions

DateFirmActionRatingReliability
5/29/2026
Keybanc
Keybanc
MaintainedOverweight49
5/22/2026
Lake Street
Lake Street
MaintainedBuy–
3/7/2023
Morgan Stanley
Morgan Stanley
MaintainedEqual Weight60
8/16/2022
JP Morgan
JP Morgan
DowngradeOverweightNeutral80
5/11/2022
Morgan Stanley
Morgan Stanley
MaintainedEqual Weight60
3/7/2022
Morgan Stanley
Morgan Stanley
MaintainedEqual Weight60
2/15/2022
Morgan Stanley
Morgan Stanley
MaintainedEqual Weight60
11/15/2021
Morgan Stanley
Morgan Stanley
MaintainedEqual Weight60
8/9/2021
Stifel
Stifel
MaintainedBuy–
8/9/2021
Morgan Stanley
Morgan Stanley
MaintainedEqual Weight60

Eulerpool Reliability Score (0–100): measures how often a firm’s bullish or bearish calls were directionally correct three months later, blended with the average return following its calls. Every rating we record is stored permanently and scores update continuously; firms with fewer than 3 measured calls are not scored yet.

Rapid Micro Biosystems Earnings Calls

2025

Rapid Micro Biosystems Earnings Estimates & Surprises

DateEPS estimateEPS ActualRevenue EstimatePrice reactionQuarterly report
8/7/2026-0.25USD-8.03 MUSD-2026 Q2
5/13/2026-0.25USD-7.75 MUSD-2026 Q1
3/12/2026-0.23USD-11.58 MUSD-2025 Q4
8/12/2025-0.26USD-7.17 MUSD-2025 Q2
11/7/2024-0.26USD-6.68 MUSD-2024 Q3
11/10/2022-0.37USD-4.03 MUSD-2022 Q3

EESG©

Eulerpool ESG Scorecard© for the Rapid Micro Biosystems stock

30/100
4
Environment
25
Social
60
Governance
E

Environment

20
Scope 1 - Direct Emissions—
Scope 2 - Indirect emissions from purchased energy—
Scope 3 - Indirect emissions within the value chain—
Total CO₂ emissions—
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather—
Pesticides—
Palm Oil—
Tobacco
Genetically modified organisms
Climate concept—
Sustainable forestry—
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency
S

Social

20
Percentage of female employees—
Percentage of women in management—
Percentage of Asian employees—
Share of Asian management—
Percentage of Hispanic/Latino employees—
Hispano/Latino Management share—
Percentage of Black employees—
Black Management Share—
Percentage of white employees—
White Management Share—
Adult content
Alcohol
Weapons—
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept—
Occupational health and safety
Catholic
G

Governance (Corporate Governance)

4
Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Rapid Micro Biosystems shareholder structure

% Name
1.12436%
Spignesi (Robert G JR)
Spignesi (Robert G JR)
0.04041%
Dimensional Fund Advisors, Ltd.
Dimensional Fund Advisors, Ltd.

Rapid Micro Biosystems Beneficial Ownership Filings (SEC 13D/G)

Free Float
58.3%
Float Shares
-
Shares Outstanding
-
StakeHolderFiling
22.20%
Bain Capital Life Sciences Fund, L.P.
Bain Capital Life Sciences Fund, L.P.
SEC ↗
13.70%
KLM GP LLC
KLM GP LLC
SEC ↗
13.70%
Kennedy Lewis Management LP
Kennedy Lewis Management LP
SEC ↗
13.70%
Kennedy Lewis Investment Holdings II LLC
Kennedy Lewis Investment Holdings II LLC
SEC ↗
13.70%
David Chene
David Chene
SEC ↗
13.70%
Darren Richman
Darren Richman
SEC ↗
12.20%
Patrick G. Enright
Patrick G. Enright
SEC ↗
12.20%
Juliet Tammenoms Bakker
Juliet Tammenoms Bakker
SEC ↗
11.80%
David Hirsch
David Hirsch
SEC ↗
11.70%
Longitude Venture Partners II, L.P.
Longitude Venture Partners II, L.P.
SEC ↗

Rapid Micro Biosystems Executives and Management Board

9 members · avg. age 60 · 22 % women

RS

Mr. Robert Spignesi (56)

President, Chief Executive Officer, Director · since 2014

1.31 M USD

Management

SW

Mr. Sean Wirtjes (55)

Chief Financial Officer

762,893.00 USD
JW

Mr. John Wilson (57)

Chief Operating Officer

725,767.00 USD
JX

Mr. James Xu

Senior Vice President - Legal, Company Secretary

–

Board of Directors

KM

Dr. Kirk Malloy (58)

Independent Chairman of the Board

124,046.00 USD
ML

Ms. Melinda Litherland (67)

Independent Director

84,046.00 USD
IL

Ms. Inese Lowenstein (52)

Independent Director

81,546.00 USD
RK

Mr. Richard Kollender (55)

Independent Director · since 2009

79,046.00 USD
NR

Mr. Natale Ricciardi (76)

Independent Director

76,546.00 USD

Frequently asked questions about Rapid Micro Biosystems

The business model of Rapid Micro Biosystems Inc is centered around providing innovative solutions for microbial quality control in the pharmaceutical and healthcare industries. The company offers automated microbial detection systems that enable faster and more efficient testing of samples, allowing pharmaceutical companies to streamline their processes and minimize the risk of contamination. Rapid Micro Biosystems Inc's technology helps customers improve product quality, reduce time-to-results, and increase operational efficiency. With its cutting-edge products and services, the company aims to revolutionize microbial testing and support the production of safe and high-quality pharmaceuticals.

Rapid Micro Biosystems Inc is primarily active in the pharmaceutical, biotechnology, and healthcare industries.

The main competitors of Rapid Micro Biosystems Inc in the market include Thermo Fisher Scientific Inc., BioMérieux SA, and Beckman Coulter Inc.

Rapid Micro Biosystems Inc is a renowned company specialized in innovative microbial detection and enumeration systems. Founded in 2006, Rapid Micro Biosystems has a rich history of developing cutting-edge technologies for the pharmaceutical, personal care, and clinical industries. The company focuses on automating and streamlining microbial quality testing processes, offering faster and more accurate results. With a wide range of solutions, including Growth Direct™, Rapid Micro Biosystems aids customers in improving their manufacturing efficiency, ensuring product safety, and minimizing risks associated with microbial contamination. Rapid Micro Biosystems Inc continues to revolutionize microbial detection, providing reliable and advanced solutions to various industries worldwide.

Rapid Micro Biosystems Inc has achieved several significant milestones. Firstly, the company successfully developed the Growth Direct™ System, a cutting-edge automated microbial detection platform used in pharmaceutical manufacturing. Additionally, Rapid Micro Biosystems Inc received strategic funding from top investors, allowing them to expand their operations and commercialize their products globally. They also gained regulatory approvals for their innovative technology, further establishing themselves as a leading player in the industry. Additionally, Rapid Micro Biosystems Inc has secured partnerships and collaborations with prominent pharmaceutical companies, strengthening their market position and facilitating growth. With these achievements, Rapid Micro Biosystems Inc continues to revolutionize microbial testing and make significant advancements in the field.

Rapid Micro Biosystems Inc is primarily present in the United States, alongside multiple international regions.

Rapid Micro Biosystems Inc represents values of innovation, efficiency, and reliability in the field of microbiology. With a strong corporate philosophy focused on advancing automation and streamlining processes, Rapid Micro Biosystems aims to transform the way microbiological testing is conducted. Their cutting-edge technologies and solutions enable faster and more accurate detection of microbial contaminants, helping industries ensure the safety and quality of their products. Through their commitment to providing reliable and efficient microbiology systems, Rapid Micro Biosystems Inc contributes to improved productivity, reduced costs, and enhanced product quality across various industries.

Analysts currently set an average price target of 8.16 USD for the Rapid Micro Biosystems stock (median: 8.16 USD), implying +288.6 % versus the latest price. The consensus is based on 10 analyst ratings.

Rapid Micro Biosystems Analyst Price Targets 2026

10 analysts currently rate the Rapid Micro Biosystems stock: 9 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Rapid Micro Biosystems to generate revenue of 39.30 M USD and earnings per share of -0.92 USD.

Rapid Micro Biosystems Analyst Price Targets 2026

Converted at the current exchange rate, the Rapid Micro Biosystems share trades at 1.82 EUR (2.10 USD).

The Rapid Micro Biosystems share (RPID) is listed on 1 stock exchanges, including: NASDAQ (RPID).

Rapid Micro Biosystems Inc. specializes in the manufacturing of automated solutions for microbiological testing and production controls. The company operates in the biotechnology industry and offers a variety of products and services. One of the main products is the Growth DirectTM, an automated system for identifying, quantifying, and monitoring microorganisms in biopharmaceutical production processes. It is used by customers in the pharmaceutical and biotechnology industries to optimize production processes and perform quality controls. Another core product is the Growth DirectTM System for environmental monitoring. It provides a fast, easy, and reliable way to perform environmental controls throughout the manufacturing process. The company also offers services such as installation, training, maintenance, and support for its systems. Rapid Micro Biosystems has a strong presence in the global market and works with customers in Asia, Europe, and North America. Overall, the company focuses on developing solutions for managing microbiological tests and process monitoring in the biotechnology and pharmaceutical industries, aiming to provide customers with more efficient process optimization and error detection.

The expected revenue of Rapid Micro Biosystems is 39.30 M USD. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Rapid Micro Biosystems is -41.22 M USD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Rapid Micro Biosystems is currently -2.27. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Rapid Micro Biosystems stock.

The price-to-sales ratio (P/S) of Rapid Micro Biosystems is currently 2.38. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Rapid Micro Biosystems stock.

The Eulerpool Quality Score for Rapid Micro Biosystems is 3/10.

The ISIN of Rapid Micro Biosystems is US75340L1044. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Rapid Micro Biosystems is RPID. The ticker symbol is used to trade Rapid Micro Biosystems shares on the stock exchange.

Rapid Micro Biosystems paid dividends every year for the past 0 years.

Rapid Micro Biosystems is assigned to the 'Health' sector.

The dividends of Rapid Micro Biosystems are distributed in USD.

All fundamentals and in-depth analysis of Rapid Micro Biosystems

Our stock analysis for Rapid Micro Biosystems stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Rapid Micro Biosystems. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

Rapid Micro Biosystems Stock
Rapid Micro Biosystems Revenue→
Rapid Micro Biosystems Stock
Rapid Micro Biosystems Net Income→
Rapid Micro Biosystems Stock
Rapid Micro Biosystems P/E→
Rapid Micro Biosystems Stock
Rapid Micro Biosystems P/S→
Rapid Micro Biosystems Stock
Rapid Micro Biosystems EBIT→
Rapid Micro Biosystems Stock
Rapid Micro Biosystems Dividend→
Rapid Micro Biosystems Stock
Rapid Micro Biosystems Directors Dealings→
Rapid Micro Biosystems Stock
Rapid Micro Biosystems Stocks→
Rapid Micro Biosystems Stock
Rapid Micro Biosystems Market capitalization→
Rapid Micro Biosystems Stock
Rapid Micro Biosystems Debt→
Rapid Micro Biosystems Stock
Rapid Micro Biosystems Liabilities→
Rapid Micro Biosystems Stock
Rapid Micro Biosystems Equity→
Rapid Micro Biosystems Stock
Rapid Micro Biosystems AAQS→
Rapid Micro Biosystems Stock
Rapid Micro Biosystems Employees→
Rapid Micro Biosystems Stock
Rapid Micro Biosystems ROE→
Rapid Micro Biosystems Stock
Rapid Micro Biosystems ROA→
Rapid Micro Biosystems Stock
Rapid Micro Biosystems ROCE→
Rapid Micro Biosystems Stock
Rapid Micro Biosystems News→
Rapid Micro Biosystems Stock
Rapid Micro Biosystems Analyst Price Targets→

Health Stocks

Rapport TherapeuticsRani Therapeutics HoldingsRaQualia PharmaRange ImpactRatchaphruek Hospital PCLRamsay Health CareRay CoRamsay Generale de SanteRayence CoRAMM PharmaRaySearch Laboratories AB (publ)Ramkhamhaeng Hospital PCLAll Stocks A–Z →